Evidence map›Paper›PMID 33852726›Full record

ReviewEndocrinology2021

Advancements in Microfluidic Systems for the Study of Female Reproductive Biology.

Vedant V Bodke, Joanna E Burdette

Abstract readReview
In one paragraph

Review in Endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. In Vitro Growth of Human Follicles: Current and Future Perspectives.International journal of molecular sciences · 2024
    Review
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Vedant V BodkeDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago 60607, USA.ORCID 0000-0002-6462-3982
Joanna E BurdetteDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago 60607, USA.ORCID 0000-0002-7271-6847

Funding

Microfluidic Models of Ovarian Cancer Preneoplastic LesionsR01CA240301 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Joanna E Burdette, Jonathan Coppeta · 2019 to 2026
$4.6M
PCOS and androgen-related disease modeling and drug testing in Multi-organ Integrated Microfluidic Reproductive PlatformUH3ES029073 · NIEHS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KIM, JI-YONG JULIE · 2019 to 2021
$3.6M
Northwestern Center for Reproductive Science Predoctoral Training Program in Reproductive Science, Medicine, and TechnologyT32HD094699 · NICHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Ji-Yong Julie Kim · 2019 to 2026
$1.3M
NCI NIH HHS R01 CA240301NICHD NIH HHS T32 HD094699NIEHS NIH HHS UH3 ES029073
6 · The paper itself

Abstract

The female reproductive tract is a highly complex physiological system that consists of the ovaries, fallopian tubes, uterus, cervix, and vagina. An enhanced understanding of the molecular, cellular, and genetic mechanisms of the tract will allow for the development of more effective assisted reproductive technologies, therapeutics, and screening strategies for female specific disorders. Traditional 2-dimensional and 3-dimensional static culture systems may not always reflect the cellular and physical contexts or physicochemical microenvironment necessary to understand the dynamic exchange that is crucial for the functioning of the reproductive system. Microfluidic systems present a unique opportunity to study the female reproductive tract, as these systems recapitulate the multicellular architecture, contacts between different tissues, and microenvironmental cues that largely influence cell structure, function, behavior, and growth. This review discusses examples, challenges, and benefits of using microfluidic systems to model ovaries, fallopian tubes, endometrium, and placenta. Additionally, this review also briefly discusses the use of these systems in studying the effects of endocrine disrupting chemicals and diseases such as ovarian cancer, preeclampsia, and polycystic ovarian syndrome.

Indexed as

MicrofluidicsAnimalsCell Culture TechniquesDimethylpolysiloxanesEndometriumFallopian TubesFemaleGenitalia, FemaleHumansLab-On-A-Chip DevicesOvarian NeoplasmsOvaryPlacentaPolycystic Ovary SyndromePolymersPre-EclampsiabaysilonDimethylpolysiloxanesPolymerspolysulfone P 1700Sulfonesfemale reproductive tractmicrofluidic systemsorgan-on-a-chip

Identifiers

PMID33852726
PMCPMC8571709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.